SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
8912565
Source:
http://linkedlifedata.com/resource/pubmed/id/8912565
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0013216
,
umls-concept:C0015133
,
umls-concept:C0015230
,
umls-concept:C0020823
,
umls-concept:C0079083
,
umls-concept:C0332281
,
umls-concept:C0600251
,
umls-concept:C1521970
,
umls-concept:C1522428
,
umls-concept:C1550147
pubmed:issue
5 Pt 1
pubmed:dateCreated
1996-12-23
pubmed:abstractText
Patients who received recombinant interleukin-1 alpha (IL-1 alpha) before chemotherapy followed by autologous bone marrow transplantation had a characteristic intertriginous cutaneous eruption that has not previously been described.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7907132
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide
,
http://linkedlifedata.com/resource/pubmed/chemical/Ifosfamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0190-9622
pubmed:author
pubmed-author:HornT DTD
,
pubmed-author:PrussickRR
,
pubmed-author:TurnerM CMC
,
pubmed-author:WilsonW HWH
pubmed:issnType
Print
pubmed:volume
35
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
705-9
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed-meshheading:8912565-Adult
,
pubmed-meshheading:8912565-Antineoplastic Agents
,
pubmed-meshheading:8912565-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:8912565-Bone Marrow Transplantation
,
pubmed-meshheading:8912565-Carboplatin
,
pubmed-meshheading:8912565-Drug Eruptions
,
pubmed-meshheading:8912565-Etoposide
,
pubmed-meshheading:8912565-Female
,
pubmed-meshheading:8912565-Humans
,
pubmed-meshheading:8912565-Ifosfamide
,
pubmed-meshheading:8912565-Interleukin-1
,
pubmed-meshheading:8912565-Male
,
pubmed-meshheading:8912565-Middle Aged
,
pubmed-meshheading:8912565-Premedication
,
pubmed-meshheading:8912565-Prospective Studies
pubmed:year
1996
pubmed:articleTitle
A characteristic eruption associated with ifosfamide, carboplatin, and etoposide chemotherapy after pretreatment with recombinant interleukin-1 alpha.
pubmed:affiliation
Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial